Bluejay Diagnostics, Inc.
BJDX
$1.17
-$0.05-4.10%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.63% | 26.97% | 0.99% | -15.42% | -14.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.75% | 4.75% | -22.21% | -37.80% | -41.84% |
| Operating Income | -18.75% | -4.75% | 22.21% | 37.80% | 41.84% |
| Income Before Tax | -7.80% | 20.96% | 19.93% | 37.81% | 35.51% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.80% | 20.96% | 19.93% | 37.81% | 35.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.80% | 20.96% | 19.93% | 37.81% | 35.51% |
| EBIT | -18.75% | -4.75% | 22.21% | 37.80% | 41.84% |
| EBITDA | -19.53% | -4.84% | 22.33% | 38.04% | 35.64% |
| EPS Basic | 98.68% | -- | -- | -- | -- |
| Normalized Basic EPS | 86.91% | -- | -- | -- | -- |
| EPS Diluted | 98.68% | -- | -- | -- | -- |
| Normalized Diluted EPS | 86.91% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 723.91% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 723.91% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |